Twist Bioscience: Fiscal Q1 Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ Twist Bioscience Corp. (TWST) on Friday reported a loss of $41.8 million in its fiscal first quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 74 cents.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.09 per share.

The maker of synthetic DNA for the biotechnology industry posted revenue of $54.2 million in the period, missing Street forecasts. Four analysts surveyed by Zacks expected $54.3 million.

For the current quarter ending in March, Twist Bioscience said it expects revenue in the range of $56.5 million.

The company expects full-year revenue in the range of $261 million to $269 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a TWST">Zacks stock report on TWST at https://www.zacks.com/ap/TWST